| Annual Financials | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 45 | 40 | 54 | 63 | 0 |
| Expenses | 39 | 35 | 45 | 52 | 0 |
| EBITDA | 6 | 5 | 9 | 12 | 0 |
| Operating Profit % | 13 % | 11 % | 16 % | 17 % | 0 % |
| Depreciation | 1 | 2 | 2 | 3 | 0 |
| Interest | 1 | 1 | 2 | 2 | 0 |
| Profit Before Tax | 4 | 3 | 5 | 7 | 0 |
| Tax | 0 | 1 | 1 | 2 | 0 |
| Net Profit | 3 | 2 | 4 | 5 | 0 |
| EPS in ₹ | 2.84 | 1.56 | 3.05 | 3.31 | 0.00 |
Onyx Biotec
Onyx Biotec
33.80
0.00
(0.00%)
Market Cap
61.29 Cr
PE Ratio
12.38
Volume
2,000.00
Day High - Low
33.80 - 33.80
52W High-Low
56.00 - 28.10
Key Fundamentals
Market Cap
61.29 Cr
EPS
3.31
PE Ratio
12.38
PB Ratio
1.10
Book Value
30.68
EBITDA
11.50
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
8.91
Debt to Equity
0.53
Actual
Company News
View All News
Onyx Biotec reports audited FY26 results with net loss of ₹21.44 lakhs vs profit of ₹495.42 lakhs in FY25, as revenue from operations rose to ₹6,946.94 lakhs.
Onyx Biotec: Weak Market Debut with 11.5% Discount on ListingNov 22, 2024
Onyx Biotec listed at ₹54 on NSE SME, 11.5% below its IPO price of ₹61. The stock recovered slightly post-listing to ₹56.75. The ₹29.34 crore IPO was oversubscribed 198 times. Proceeds will be used for manufacturing upgrades, loan repayment, and corporate purposes.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,878.20 | #1 4,50,643.09 | 40.81 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 64.89 | |
6,760.50 | 1,79,470.03 | 74.13 | 9,712.00 | 18.67 | 2,191 | -1.02 | 64.06 | |
4,405.70 | 1,49,108.91 | 65.68 | 11,539.40 | 6.99 | 1,911 | 26.24 | 58.52 | |
1,432.10 | 1,15,682.27 | 30.09 | 27,711.70 | -2.46 | 3,783 | -55.32 | 69.78 | |
1,336.70 | 1,11,566.73 | 26.16 | 33,593.30 | -0.44 | 3,998 | -86.05 | 59.87 | |
2,276.20 | 1,04,032.18 | #1 19.28 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 46.11 | |
2,503.00 | 1,03,325.11 | 56.36 | 12,744.20 | 20.90 | 2,007 | 7.65 | 73.37 | |
1,011.70 | 1,01,800.69 | 19.85 | 23,511.00 | 18.55 | 4,615 | -0.32 | 69.47 | |
1,511.80 | 87,805.59 | 25.16 | 32,345.60 | 9.43 | 3,484 | 7.59 | 73.83 | |
1,323.60 | 71,455.42 | 79.78 | 6,812.90 | #1 21.03 | 884 | 21.18 | 80.26 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
17.07 %
Net Income Growth
38.89 %
Cash Flow Change
-6.58 %
ROE
-38.00 %
ROCE
1.02 %
EBITDA Margin (Avg.)
16.10 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 37 | 59 | 74 | 91 | 95 |
| Fixed Assets | 17 | 43 | 44 | 41 | 43 |
| Current Assets | 14 | 15 | 30 | 49 | 51 |
| Capital Work in Progress | 4 | 0 | 0 | 0 | 4 |
| Investments | 0 | 0 | 0 | 0 | 14 |
| Other Assets | 16 | 16 | 31 | 50 | 0 |
| Total Equity & Liabilities | 37 | 59 | 74 | 91 | 95 |
| Current Liabilities | 10 | 20 | 23 | 26 | 33 |
| Non Current Liabilities | 10 | 20 | 26 | 10 | 7 |
| Total Equity | 16 | 18 | 25 | 56 | 55 |
| Reserve & Surplus | 11 | 12 | 12 | 38 | 37 |
| Share Capital | 6 | 6 | 13 | 18 | 18 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | -4 | 2 | 7 |
| Investing Activities | -6 | -23 | -3 | 1 |
| Operating Activities | 1 | 2 | 2 | 1 |
| Financing Activities | 5 | 16 | 3 | 5 |
Share Holding
| % Holding | Nov 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
| Promoter | 65.10 % | 65.10 % | 65.10 % | 65.10 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 1.07 % |
| DIIs | 0.03 % | 0.00 % | 0.00 % | 2.39 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 18.96 % | 18.97 % | 22.64 % | 23.15 % |
| Others | 15.92 % | 15.94 % | 12.27 % | 8.29 % |
| No of Share Holders | 1,181 | 551 | 640 | 586 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 10 Jan 2025 |  Quarterly Result Announcement | NA | 10 Jan 2025 | 90.15 | 78.95 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 49.25 | 49.90 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 39.00 | 42.80 |
| 14 May 2026 | Quarterly Result Announcement | NA | 14 May 2026 | 34.70 | 33.00 |
Technical Indicators
RSI(14)
Neutral 50.68
ATR(14)
Less Volatile 1.80
STOCH(9,6)
Neutral 63.86
STOCH RSI(14)
Oversold 18.78
MACD(12,26)
Bullish 0.05
ADX(14)
Weak Trend 9.75
UO(9)
Bearish 53.67
ROC(12)
Uptrend And Accelerating 4.81
WillR(14)
Neutral -46.88
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
